Efficacy of Quanduzhong capsules in regulating blood pressure circadian rhythm in essential hypertension: a multicenter, randomized, add-on controlled clinical trial
Frontiers in Pharmacology · 08.10.2025 · 16
DOI: 10.3389/fphar.2025.1659073 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 08.10.2025. Verfasst von Bi-Hua Tang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, China. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Abnormal circadian rhythm of blood pressure is recognized as an independent risk factor for target organ damage in the heart, brain, and kidneys. Eucommia ulmoides Oliv [Eucommiaceae, Eucommiae cortex] , a traditional Chinese medicine, has been reported to exhibit antihypertensive effects and may regulate blood pressure variability. This study aimed to evaluate the efficacy and safety of Quanduzhong capsules in regulating the circadian rhythm of blood pressure in patients with essential hypertension.
Methods
We designed a randomized controlled clinical trial. A total of 136 participants who had essential hypertension and abnormal circadian rhythm of blood pressure were randomly assigned to the test or control group, each comprising 68 individuals, using the random number table method. Both groups maintained their original Western antihypertensive medicine regimen, with the test group receiving additional treatment of Quanduzhong capsules (administered twice daily, 1.48 g each time). The treatment duration for both groups was 12 weeks. The patients were visited at baseline and at the end of the 4th, 8th, and 12th weeks of the intervention. Their 24-h ambulatory blood pressure and clinic blood pressure were measured at baseline and the end of 12th weeks. Primary outcomes included the recovery rate of dipper blood pressure rhythm, the standard deviation of blood pressure (SD), and the coefficient of variation of blood pressure (CV).
Results
After 12 weeks of treatment, the results in the full analysis set and in the per-protocol set showed no statistically significant differences between the treatment group and the control group in SD and CV. However, among the subjects who did not use calcium channel blockers, the treatment group demonstrated significantly better improvements in 24-h standard deviation of diastolic blood pressure ( P < 0.05 ) than the control group.
Conclusion
Our findings suggest that Quanduzhong capsules can effectively improve the circadian rhythm of blood pressure without calcium channel blockers. Clinical Trial Registration https://www.chictr.org.cn/showproj.html?proj=127240 , identifier ChiCTR2100046830.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, China.
- School of Acupuncture and Tuina, School of Regimen and Rehabilitation, Nanjing University of Chinese Medicine, Nanjing, China.
- Institute of Basic Theory for Chinese Medicine, China Academy of Chinese Medicine Science, Beijing, China.
- Jiangsu Province Hospital of TCM, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, China.
- Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China.
- Jiangxi Puzheng Pharmaceutical Co, Ltd., Jian, China.
Zitieren
APA
Tang, B. H., Zhou, C. H., He, R. M., Li, Z. Y., Wang, J. C., Cui, Y. T., Zou, J. X., Xiao, J. P., Zhou, Z. G., Li, X. F., Yang, Y., & Hu, J. Q. (2025). Efficacy of Quanduzhong capsules in regulating blood pressure circadian rhythm in essential hypertension: a multicenter, randomized, add-on controlled clinical trial. Frontiers in Pharmacology, 16. https://doi.org/10.3389/fphar.2025.1659073
Vancouver
Tang BH, Zhou CH, He RM, Li ZY, Wang JC, Cui YT, et al. Efficacy of Quanduzhong capsules in regulating blood pressure circadian rhythm in essential hypertension: a multicenter, randomized, add-on controlled clinical trial. Frontiers in Pharmacology. 2025;16. doi:10.3389/fphar.2025.1659073
BibTeX
@article{Tang2025,
author = {Tang, Bi-Hua and Zhou, Cong-Hui and He, Run-Ming and Li, Zi-Yun and Wang, Jin-Cheng and Cui, Yu-Ting and Zou, Jia-Xi and Xiao, Jun-Ping and Zhou, Zhi-Gang and Li, Xiao-Feng and Yang, Yan and Hu, Jing-Qing},
title = {Efficacy of Quanduzhong capsules in regulating blood pressure circadian rhythm in essential hypertension: a multicenter, randomized, add-on controlled clinical trial},
journal = {Frontiers in Pharmacology},
year = {2025},
volume = {16},
doi = {10.3389/fphar.2025.1659073}
}
EUVIMED